SRX sierra rutile holdings limited

Lung cancer treatment

  1. 8,918 Posts.
    lightbulb Created with Sketch. 32
    Not directly SRX. For the Medics, does this treatment increase the chances of SIRT being viable?

    And why is this not used for liver cancers, or is it?


    They got some pretty good data..
    ASTRO: SBRT doubles survival in early-stage lung cancer

    http://www.auntminnie.com/index.aspx?sec=nws&sub=rad&pag=dis&ItemID=115212

    At the four-year follow-up point, overall survival had more than doubled for the SBRT group, with 28.5% of patients still alive, compared with 12.7% of patients in the conventional radiation therapy group, according to the researchers.
    With respect to lung cancer-specific survival, the SBRT group had a rate of 50.4% at the four-year mark, compared with 33.9% in the conventional group. The researchers noted that the increase in survival occurred with rising use of SBRT in the Veterans Affairs system, from 4.7% to 60.3%.
    When analyzing the data for multiple variables, they found that using SBRT was associated with a nearly 30% reduction in risk of death, with a hazard ratio of 0.72
 
Add to My Watchlist
What is My Watchlist?
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.

Currently unlisted public company.

arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.